<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04864171</url>
  </required_header>
  <id_info>
    <org_study_id>M30-084-4</org_study_id>
    <nct_id>NCT04864171</nct_id>
  </id_info>
  <brief_title>REASSURE-NIRS Registry</brief_title>
  <acronym>REASSURENIRS</acronym>
  <official_title>REvelation of PAthophySiological PhenotypeS of VUlneRable Lipid-Rich PlaquE on Near-InfraRed Spectroscopy: REASSURE-NIRS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cerebral and Cardiovascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cerebral and Cardiovascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      RESSURE-NIRS registry is designed to investigate clinical and pathophysiological&#xD;
      characteristics of NIRS-derived lipid-rich plaque in patients with coronary artery disease.&#xD;
      This is an on-going multi-center prospective registry in Japan.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NIRS imaging is an invasive intravascular imaging modality to quantitatively visualize&#xD;
      lipid-rich atheroma in vivo. While NIRS-derived lipid-rich plaque has been shown to associate&#xD;
      with cardiovascular events, there is limited clinical data about the association of this&#xD;
      high-risk plaque with risk factors, medication use, prognosis and response of PCI.&#xD;
      RESSURE-NIRS registry is an on-going multi-center prospective registry in Japan, which enroll&#xD;
      subjects with coronary artery disease who received NIRS imaging to evaluate coronary&#xD;
      atherosclerosis. The primary outcome is maximum 4-mm lipid core burden index at coronary&#xD;
      lesions measured by NIRS imaging. Secondary major outcomes include entire lipid core burden&#xD;
      index, plaque volume, plaque attenuation and echo-lucent area. The anticipated number of&#xD;
      study subjects is 2000 cases.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>max 4mm lipid core burden index</measure>
    <time_frame>It is measured during the procedure of percutaneous coronary intervention</time_frame>
    <description>the extent of lipidic materials at coronary lesions</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Lipid-Rich Atherosclerosis of Coronary Artery</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>near-infrared spectroscopy</intervention_name>
    <description>Near-infrared spectroscopy is an intravascular imaging device to visualize lipid-rich plaque of coronary artery.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population should be patients with coronary artery disease who requires coronary&#xD;
        angiography and/or percutaneous coronary intervention with NIRS imaging&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        patients with coronary artery disease clinical indication for coronary angiography and/or&#xD;
        percutaneous coronary intervention visualization of coronary lesions with NIRS&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        poor quality of NIRS images&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu Kataoka, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral &amp; Cardiovascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu Kataoka, MD</last_name>
    <phone>+81661701070</phone>
    <phone_ext>60189</phone_ext>
    <email>yu.kataoka@ncvc.go.jp</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kota Murai, MD</last_name>
    <phone>+81661701070</phone>
    <phone_ext>60162</phone_ext>
    <email>murai.kota11@ncvc.go.jp</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Miyazaki Medical Association Hospital</name>
      <address>
        <city>Miyazaki</city>
        <zip>8802102</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kensaku Nishihira, MD</last_name>
      <phone>+81985779101</phone>
      <phone_ext>60111</phone_ext>
      <email>nishihira@med.miyazaki-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Kensaku Nishihira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cerebral &amp; Cardiovascular Center</name>
      <address>
        <city>Suita</city>
        <zip>5648565</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Kataoka, MD</last_name>
      <phone>+81661701070</phone>
      <phone_ext>60189</phone_ext>
      <email>yu.kataoka@ncvc.go.jp</email>
    </contact>
    <investigator>
      <last_name>Yu Kataoka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kota Murai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Satoshi Kitahara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Takamasa Iwai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <reference>
    <citation>Kataoka Y, Puri R, Andrews J, Honda S, Nishihira K, Asaumi Y, Noguchi T, Yasuda S, Nicholls SJ. In vivo visualization of lipid coronary atheroma with intravascular near-infrared spectroscopy. Expert Rev Cardiovasc Ther. 2017 Oct;15(10):775-785. doi: 10.1080/14779072.2017.1367287. Epub 2017 Aug 28. Review.</citation>
    <PMID>28846060</PMID>
  </reference>
  <reference>
    <citation>Puri R, Madder RD, Madden SP, Sum ST, Wolski K, Muller JE, Andrews J, King KL, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nissen SE, Virmani R, Maehara A, Mintz GS, Nicholls SJ. Near-Infrared Spectroscopy Enhances Intravascular Ultrasound Assessment of Vulnerable Coronary Plaque: A Combined Pathological and In Vivo Study. Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2423-31. doi: 10.1161/ATVBAHA.115.306118. Epub 2015 Sep 3.</citation>
    <PMID>26338299</PMID>
  </reference>
  <reference>
    <citation>Kitahara S, Kataoka Y, Sugane H, Otsuka F, Asaumi Y, Noguchi T, Yasuda S. In vivo imaging of vulnerable plaque with intravascular modalities: its advantages and limitations. Cardiovasc Diagn Ther. 2020 Oct;10(5):1461-1479. doi: 10.21037/cdt-20-238. Review.</citation>
    <PMID>33224768</PMID>
  </reference>
  <results_reference>
    <citation>Kitahara S, Kataoka Y, Miura H, Nishii T, Nishimura K, Murai K, Iwai T, Nakamura H, Hosoda H, Matama H, Doi T, Nakashima T, Honda S, Fujino M, Nakao K, Yoneda S, Nishihira K, Kanaya T, Otsuka F, Asaumi Y, Tsujita K, Noguchi T, Yasuda S. The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis. Atherosclerosis. 2021 Apr;322:1-7. doi: 10.1016/j.atherosclerosis.2021.02.019. Epub 2021 Feb 24.</citation>
    <PMID>33706078</PMID>
  </results_reference>
  <results_reference>
    <citation>Imamoto K, Kataoka Y, Hosoda H, Noguchi T. Suboptimal lipoprotein (a) control and residual plaque instability despite proprotein convertase subtilisin/kexin type 9 inhibitor use in heterozygous familial hypercholesterolaemia: insights from serial near-infrared spectroscopy imaging. Eur Heart J. 2021 Jun 7;42(22):2218-2219. doi: 10.1093/eurheartj/ehab218.</citation>
    <PMID>33822931</PMID>
  </results_reference>
  <results_reference>
    <citation>Hosoda H, Kataoka Y, Otsuka F, Yasuda S. Severely calcified lipidic atheroma on intravascular ultrasound and near-infrared spectroscopy imaging: its association with slow-flow phenomenon during percutaneous coronary intervention. Eur Heart J Case Rep. 2019 Jun 1;3(2). pii: ytz078. doi: 10.1093/ehjcr/ytz078.</citation>
    <PMID>31449658</PMID>
  </results_reference>
  <results_reference>
    <citation>Nishihira K, Yamashita A, Kataoka Y, Shibata Y, Asada Y. Visualization of oxidized low-density lipoprotein at lipid-rich plaque in a ST-segment elevation myocardial infarction case with heterozygous familial hypercholesterolaemia: insights from near-infrared spectroscopy and histopathological analysis. Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1316. doi: 10.1093/ehjci/jez156.</citation>
    <PMID>31180473</PMID>
  </results_reference>
  <results_reference>
    <citation>Kaichi R, Kataoka Y, Yasuda S. Erupted coronary atheroma: insights from multi-modality imaging. Int J Cardiovasc Imaging. 2018 Oct;34(10):1669-1671. doi: 10.1007/s10554-018-1378-1. Epub 2018 May 24.</citation>
    <PMID>29799063</PMID>
  </results_reference>
  <results_reference>
    <citation>Nishihira K, Otsuka F, Kataoka Y, Asaumi Y, Kaneta K, Nakano H, Ohta-Ogo K, Ishibashi-Ueda H, Noguchi T, Yasuda S. Embolization of Neoatherosclerosis After Percutaneous Coronary Intervention: Insights From Near-Infrared Spectroscopy Imaging and Histopathological Analysis. Circ Cardiovasc Interv. 2018 Feb;11(2):e006175. doi: 10.1161/CIRCINTERVENTIONS.117.006175.</citation>
    <PMID>29445002</PMID>
  </results_reference>
  <results_reference>
    <citation>Nishihira K, Asaumi Y, Kataoka Y, Ishibashi-Ueda H, Yasuda S. In vivo comparison of lipid-rich plaque on near-infrared spectroscopy with histopathological analysis of coronary atherectomy specimens. Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):116. doi: 10.1093/ehjci/jex247.</citation>
    <PMID>29040461</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 24, 2021</study_first_submitted>
  <study_first_submitted_qc>April 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cerebral and Cardiovascular Center</investigator_affiliation>
    <investigator_full_name>Yu Kataoka</investigator_full_name>
    <investigator_title>Chief consultant</investigator_title>
  </responsible_party>
  <keyword>near-infrared spectroscopy</keyword>
  <keyword>lipid-rich plaque</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>intravascular imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

